Table 1. Reported sensitivity/specificity of the UroSEEK assay for the ‘early detection cohort’ from the 2018 study (2).
| Urothelial cancer | Non-malignant | Total | |
|---|---|---|---|
| UroSEEK + | 145 (85%) | 26 | 171 |
| UroSEEK − | 30 | 369 (92%) | 399 |
| Total | 175 | 395 | 570 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.